NIPOCALIMAB-AAHU: 32 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
32
Total FAERS Reports
0
Deaths Reported
5
Hospitalizations
32
As Primary/Secondary Suspect
Prescription
Status
FDA Application: 761430 ·
First Report: 20250101 · Latest Report: 20250922
What Are the Most Common NIPOCALIMAB-AAHU Side Effects?
#1 Most Reported
Oedema peripheral
5 reports (15.6%)
#2 Most Reported
Drug ineffective
4 reports (12.5%)
#3 Most Reported
Myasthenia gravis
3 reports (9.4%)
All NIPOCALIMAB-AAHU Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Oedema peripheral | 5 | 15.6% | 0 | 0 |
Who Reports NIPOCALIMAB-AAHU Side Effects? Age & Gender Data
Gender: 59.1% female, 40.9% male. Average age: 60.3 years. Most reports from: US. View detailed demographics →
Is NIPOCALIMAB-AAHU Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2025 | 11 | 0 | 3 |
What Is NIPOCALIMAB-AAHU Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 18 |
| Myasthenia gravis | 14 |
Official FDA Label for NIPOCALIMAB-AAHU
Official prescribing information from the FDA-approved drug label.